The optimal immune globulin replacement dosages required over time to minimize infection risks in patients with Primary Antibody Deficiencies are not definitely established. As with many interventions, there may be specific subgroups of patients who are more likely to benefit from treatment with higher or lower dosages. The aim of the study was to verify the efficacy of a rationale for individualized immune globulin utilization and to elucidate the effects of care on patient outcome.
Milito, C., Pulvirenti, F., Pesce, A., Digiulio, M., Pandolfi, F., Visentini, M., Quinti, I., Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies, <<JOURNAL OF CLINICAL IMMUNOLOGY>>, 2014; 34 (7): 813-819. [doi:10.1007/s10875-014-0081-9] [http://hdl.handle.net/10807/60943]
Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies
Pandolfi, Franco;
2014
Abstract
The optimal immune globulin replacement dosages required over time to minimize infection risks in patients with Primary Antibody Deficiencies are not definitely established. As with many interventions, there may be specific subgroups of patients who are more likely to benefit from treatment with higher or lower dosages. The aim of the study was to verify the efficacy of a rationale for individualized immune globulin utilization and to elucidate the effects of care on patient outcome.File | Dimensione | Formato | |
---|---|---|---|
unpaywall-bitstream--704701423.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
473.55 kB
Formato
Adobe PDF
|
473.55 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.